Salamanca man charged with murder in city
Breaking News
Salamanca man charged with murder in city
September 27, 2025
SALAMANCA — A Salamanca man was being held for the murder of another person in the city, Salamanca police reported Saturday. Andrew C. Skye, 35, of 31...
Home Online Features Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now received Fast Track designation
Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren’s disease, has now received Fast Track designation
Hand-out
Press Releases
Johnson & Johnson  
March 18, 2025

Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren’s disease, has now received Fast Track designation

Sjögren's disease (SjD) is a prevalent, debilitating autoantibody disease with no FDA-approved advanced treatments

logo salamanca press

Salamanca Press

email salamanca press
Local & Social